Pericardiocentesis Procedure Market Outlook - 2027
Pericardiocentesis is a procedure done to remove fluid that has built up in the sac around the heart (pericardium). It is carried out using a small needle and catheter to drain excess fluid later the fluid is tested to help diagnose an infection, cancer, or the cause of extra fluid surrounding the heart. This is an invasive procedure carried out by surgeon, an interventional cardiologist or cardiologist and surgeons. The indications that lead to the need of pericardiocentesis procedure are kidney failure, hypothyroidism, cancer, HIV/AIDS, medications such as Nydrazid for tuberculosis & Dilantin for seizures, trauma near the heart, metastatic cancer from other organs, autoimmune diseases viral, bacterial, fungal, or parasitic infections, congestive heart failure, and ventricular aneurysm rupture.
Covid-19 Scenario Analysis:
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), it was first identified during an investigation into an outbreak in Wuhan, China. A 47-year-old presented with chest pain and breathlessness. She was positive for COVID-19. Echocardiogram showed cardiac tamponade, and pericardiocentesis was performed. This is the first reported case of COVID-19-associated cardiac tamponade. This case report highlights the first cardiac tamponade case in COVID-19. Cardiac tamponade is an important differential to consider in a deteriorating patient with COVID-19. Pericardiocentesis is a heart complication caused because of Viral or bacterial infection although there are no conclusive study to know if Covid-19 cause’s pericardiocentesis but there is a possibility that those patients are susceptible to pericardiocentesis because of Viral or Bacterial infection. There is an expected rush of COVID-19 patients which necessities allocation of valuable resources towards managing these patients. This has prompted cancelling of elective surgeries the world over. The need to safeguard doctors and their patients has prompted the surgeons to develop their own protocols to tide over the pandemic situation. The decision for surgical care is based on surgeon’s own surgical and clinical judgment and assessment of resource availability.
Top Impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
Increased preference for Invasive heart surgery:
The first pericardiocentesis procedure was formulated in 1911, based on subxiphoid approach used for the procedure, which is used for the blind pericardiocentesis procedure for decades, despite its significant morbidity of 50% and mortality rates 6%. In subsequent years, the techniques recommended for safe and successful pericardiocentesis have considerably improved, particularly with the introduction of fluoroscopic, electrocardiographic and echocardiographic guidance, and with the description of approaches other than the substernal one such as apical parasternal. Pericardial effusion (PE) is common in cancer patients but the optimal therapeutic approach is not well defined. Percutaneous pericardiocentesis is less invasive than surgery, but its long-term effectiveness and safety are not well documented. Minimally invasive heart surgery i.e. Pericardiocentesis can be performed to treat a heart conditions like pericardial aspiration and/or drainage of the pericardium i.e. drainage of fluid from pericardium as compared with open-heart surgery, this type of surgery might mean less pain and a quicker recovery for many people. The echo-cardiograph approach is the one mostly used to carry out the procedure of pericardiocentesis as it has the lowest mortality rate and highest success rate as compared to all the other procedures. Thus the development of such invasive treatment options will boost Pericardiocentesis procedure market.
Increase in prevalence of heart diseases:
A total of 131,945 patients underwent either pericardiocentesis or pericardiotomy during a five years study by NIS. Pericardiocentesis was done on 49,854(37.8%) and pericardiotomy was done on 82,090 (62.2%). The per annum pericardiocentesis rate increased from 9,171 in 2005 to 11,088 in 2009 (20.9% increase) whereas the pericardiotomy rates were essentially the same during the study period. The risk adjusted in-hospital mortality was significantly higher in the pericardiocentesis group than in the pericardiotomy group (15.5% versus 10.3% p<0.001). The patients suffering from Cancer undergo pericardiocentesis for the drainage of lumps as Pericardiocentesis with intrapericardial sclerotherapy is as effective as open surgical drainage for the management of malignant pericardial effusions in case of cancer especially in cases of breast cancer. Among the elderly, the spectrum of etiologist for pericardial effusion does not differ significantly from the rest of the population. The underlying cause of effusion can usually be inferred from the clinical picture. One study in 322 patients has reported around 60% of cases had a known cause of pericardial effusion and not just due to old age. Uremic and tuberculosis pericarditis were reported previously to be the most common causes of pericardial disease in the southern part of Saudi Arabia (Asia region), which may probably reflect the spectrum of diseases prevailing in that area such as viral and cancer diseases causing the spike.
The high cost of the procedure and lack of skilled professional to carry out advanced procedure are causing restrains to the Pericardiocentesis procedure market.
Benefits of the Report:
- The following study explains the Pericardiocentesis procedure and its approaches along with the trends and the required equipment’s and technical expertise.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Pericardiocentesis procedure market.
- The current market is quantitatively analyzed to highlight the global pericardiocentesis procedure market.
- The exhaustive analysis of the pericardiocentesis procedure market by products that are required helps in understanding the types of procedures that are currently being used along with the variants that would gain prominence in the future.
- What is the pericardiocentesis procedure and the various procedure approaches available in the market?
- What the current trends and approaches that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Pericardiocentesis Procedures Market Report Highlights
By End user
Key Market Players
Buddhist Tzu Chi Medical Foundation, Mediclinic International, Apollo Hospitals Enterprise Ltd, Cleveland Clinic, Mayo Clinic, Massachusetts General Hospital, J.W. Goethe University Hospital, Hospitals of the University of Pennsylvania-Penn Presbyterian, New York-Presbyterian Hospital-Columbia and Cornell, Smidt Heart Institute
Saint George Hospital, Cleveland Clinic, The Johns Hopkins Hospital